<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">590</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2016-12-4-110-118</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак мочевого пузыря</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The cytomorphologic classification of urinary pathology. The Paris System, 2016</article-title><trans-title-group xml:lang="ru"><trans-title>Цитоморфологическая классификация уринарной патологии. Парижская система 2016 г.</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Savostikova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Савостикова</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>23 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 23</p></bio><email>savostikovamv@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kudaybergenova</surname><given-names>A. G.</given-names></name><name xml:lang="ru"><surname>Кудайбергенова</surname><given-names>А. Г.</given-names></name></name-alternatives><bio xml:lang="en"><p>23 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 23</p></bio><email>asel1972@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fedoseeva</surname><given-names>E. S.</given-names></name><name xml:lang="ru"><surname>Федосеева</surname><given-names>Е. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>23 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 23</p></bio><email>dorigen@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center</institution></aff><aff><institution xml:lang="ru">ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-12-30" publication-format="electronic"><day>30</day><month>12</month><year>2016</year></pub-date><volume>12</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>110</fpage><lpage>118</lpage><history><date date-type="received" iso-8601-date="2016-08-02"><day>02</day><month>08</month><year>2016</year></date><date date-type="accepted" iso-8601-date="2016-10-04"><day>04</day><month>10</month><year>2016</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/590">https://oncourology.abvpress.ru/oncur/article/view/590</self-uri><abstract xml:lang="en"><p>The paper presents the Paris System for Reporting Urinary Cytology developed by the joint efforts of cytologists, pathologists and urologists in April 2016. We describe 7 accepted categories of cytological diagnoses, the risk of malignancy and recommended clinical management of patients with urinary pathology.</p></abstract><trans-abstract xml:lang="ru"><p>В работе представлена Парижская система оценки уринарной цитопатологии, разработанная совместными усилиями цитологов, патологов и урологов в апреле 2016 г. Показаны 7 принятых категорий цитологических заключений, риск выявления злокачественной опухоли и рекомендуемая тактика ведения пациентов при уринарной патологии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>oncourology</kwd><kwd>cytology</kwd><kwd>urine</kwd><kwd>urothelial carcinoma</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>онкоурология</kwd><kwd>цитология</kwd><kwd>моча</kwd><kwd>уротелиальный рак</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Статистика злокачественных новообразований в России и странах СНГ в 2012 году. Под ред. М.И. Давыдова, Е.М. Аксель. М.: Издательская группа РОНЦ, 2014. 226 с. [Statistics of malignant tumors in Russia and CIS countries in 2012. Eds. by: М.I. Davydov, Е.М. Аksel’. Мoscow: Izdatel’skaya gruppa RONTS, 2014. 226 p. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Статистика злокачественных новообразований в России и странах СНГ в 2012 году. Под ред. М.И. Давыдова, Е.М. Аксель. М.: Издательская группа РОНЦ, 2014. 226 с. [Statistics of malignant tumors in Russia and CIS countries in 2012. Eds. by: М.I. Davydov, Е.М. Аksel’. Мoscow: Izdatel’skaya gruppa RONTS, 2014. 226 p. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Amin M.B., Smith S.C., Reuter V.E. et al. Update for the practicing pathologist: the International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Mod Pathol 2014;28(5)1–19. PMID: 25412849. PMCID: PMC5009623. DOI: 10.1038/modpathol.2014.158.</mixed-citation><mixed-citation xml:lang="ru">Amin M.B., Smith S.C., Reuter V.E. et al. Update for the practicing pathologist: the International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Mod Pathol 2014;28(5)1–19. PMID: 25412849. PMCID: PMC5009623. DOI: 10.1038/modpathol.2014.158.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Rosenthal D.L., Wojcik E.M., Kurtycz D.F.I. The Paris System for reporting urinary cytology. Springer, 2016.</mixed-citation><mixed-citation xml:lang="ru">Rosenthal D.L., Wojcik E.M., Kurtycz D.F.I. The Paris System for reporting urinary cytology. Springer, 2016.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Galed-Placed I., Valbuena-Ruvira L. Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma. Diagn Cytopathol 2011;39(12):933–7. PMID: 22081531. DOI: 10.1002/dc.21579.</mixed-citation><mixed-citation xml:lang="ru">Galed-Placed I., Valbuena-Ruvira L. Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma. Diagn Cytopathol 2011;39(12):933–7. PMID: 22081531. DOI: 10.1002/dc.21579.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Geetha D., Tong B.C., Racusen L. et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002;73(12):1933–6. PMID: 12131691.</mixed-citation><mixed-citation xml:lang="ru">Geetha D., Tong B.C., Racusen L. et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002;73(12):1933–6. PMID: 12131691.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Wojcik E.M. What should not be reported as atypia in urine cytology. J Am Soc Cytopathol 2015;4:30–6.</mixed-citation><mixed-citation xml:lang="ru">Wojcik E.M. What should not be reported as atypia in urine cytology. J Am Soc Cytopathol 2015;4:30–6.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Piaton E., Decaussin-Petrucci M., MegeLechevallier F. et al. Diagnostic terminology for urinary cytology reports including the new subcategories “atypical urothelial cells of undetermined significance” (AUC-US) and “cannot exclude high grade” (AUC-H). Cytopathology 2014;25:27–38.</mixed-citation><mixed-citation xml:lang="ru">Piaton E., Decaussin-Petrucci M., MegeLechevallier F. et al. Diagnostic terminology for urinary cytology reports including the new subcategories “atypical urothelial cells of undetermined significance” (AUC-US) and “cannot exclude high grade” (AUC-H). Cytopathology 2014;25:27–38.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Sternberg I., Rona R., Olsfanger S. et al. The clinical significance of class III (suspicious) urine cytology. Cytopathology 2011;22(5):329–33. PMID: 21114557. DOI: 10.1111/j.1365-2303.2010.00827.x.</mixed-citation><mixed-citation xml:lang="ru">Sternberg I., Rona R., Olsfanger S. et al. The clinical significance of class III (suspicious) urine cytology. Cytopathology 2011;22(5):329–33. PMID: 21114557. DOI: 10.1111/j.1365-2303.2010.00827.x.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Vanden Bussche C.J., Sathiyamoorthy S., Owens C.L. et al. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study. Cancer Cytopathol 2013;121(1):21–8. PMID: 23192913. DOI: 10.1002/cncy.21254.</mixed-citation><mixed-citation xml:lang="ru">Vanden Bussche C.J., Sathiyamoorthy S., Owens C.L. et al. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study. Cancer Cytopathol 2013;121(1):21–8. PMID: 23192913. DOI: 10.1002/cncy.21254.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Ton Nu T.N., Kassouf W., Ahmadi-Kaliji B. et al. The value of the “suspicious for urothelial carcinoma” cytology category: a correlative study of 4 years including 337 patients. Cancer Cytopathol 2014;122(11):796–803. PMID: 24909774. DOI: 10.1002/cncy.21449.</mixed-citation><mixed-citation xml:lang="ru">Ton Nu T.N., Kassouf W., Ahmadi-Kaliji B. et al. The value of the “suspicious for urothelial carcinoma” cytology category: a correlative study of 4 years including 337 patients. Cancer Cytopathol 2014;122(11):796–803. PMID: 24909774. DOI: 10.1002/cncy.21449.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Murphy W.M., Soloway M.S., Jukkola A.F. et al. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984;53(7):1555–65. PMID: 6697294.</mixed-citation><mixed-citation xml:lang="ru">Murphy W.M., Soloway M.S., Jukkola A.F. et al. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984;53(7):1555–65. PMID: 6697294.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Raab S.S., Lenel J.C., Cohen M.B. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 1994;74(5):1621–6. PMID: 8062194.</mixed-citation><mixed-citation xml:lang="ru">Raab S.S., Lenel J.C., Cohen M.B. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 1994;74(5):1621–6. PMID: 8062194.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Hughes J.H., Raab S.S., Cohen M.B. The cytologic diagnosis of low-grade transitional cell carcinoma. Am J Clin Pathol 2000;114:59–67. PMID: 11996171.</mixed-citation><mixed-citation xml:lang="ru">Hughes J.H., Raab S.S., Cohen M.B. The cytologic diagnosis of low-grade transitional cell carcinoma. Am J Clin Pathol 2000;114:59–67. PMID: 11996171.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Xin W., Raab S.S., Michael C.W. Lowgrade urothelial carcinoma: reappraisal of the cytologic criteria on ThinPrep. Diagn Cytopathol 2003;29(3):125–9. PMID: 12951678. DOI: 10.1002/dc.10311.</mixed-citation><mixed-citation xml:lang="ru">Xin W., Raab S.S., Michael C.W. Lowgrade urothelial carcinoma: reappraisal of the cytologic criteria on ThinPrep. Diagn Cytopathol 2003;29(3):125–9. PMID: 12951678. DOI: 10.1002/dc.10311.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Mai K.T., Ball C.G., Kos Z. et al. Threedimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low-grade urothelial neoplasia. Diagn Cytopathol 2014;42(7):555–63. PMID: 24273035. DOI: 10.1002/dc.23069.</mixed-citation><mixed-citation xml:lang="ru">Mai K.T., Ball C.G., Kos Z. et al. Threedimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low-grade urothelial neoplasia. Diagn Cytopathol 2014;42(7):555–63. PMID: 24273035. DOI: 10.1002/dc.23069.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Nathan N.A., Narayan E., Smith M.M., Horn M.J. Cell block cytology. Improved preparation and its efficacy in diagnostic cytology. Am J Clin Pathol 2000;114(4): 599–606. PMID: 11026107. DOI: 10.1309/G035-P2MM-D1TM-T5QE.</mixed-citation><mixed-citation xml:lang="ru">Nathan N.A., Narayan E., Smith M.M., Horn M.J. Cell block cytology. Improved preparation and its efficacy in diagnostic cytology. Am J Clin Pathol 2000;114(4): 599–606. PMID: 11026107. DOI: 10.1309/G035-P2MM-D1TM-T5QE.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Reid M.D., Osunkoya A.О., Siddiqui M.T., Looney S.W. Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of in terobserver and intraobserver agreement. Int J Clin Exp Pathol 2012;5(9):882–91. PMID: 23119105. PMCID: PMC3484494.</mixed-citation><mixed-citation xml:lang="ru">Reid M.D., Osunkoya A.О., Siddiqui M.T., Looney S.W. Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of in terobserver and intraobserver agreement. Int J Clin Exp Pathol 2012;5(9):882–91. PMID: 23119105. PMCID: PMC3484494.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Raab S.S., Grzybicki D.M., Vrbin C.M., Geisinger K.R. Urine cytology discrepancies: frequency, causes, and outcomes. Am J Clin Pathol 2007;127(6):946–53. PMID: 17509992. DOI: 10.1309/XUVXFXMFPL7TELCE.</mixed-citation><mixed-citation xml:lang="ru">Raab S.S., Grzybicki D.M., Vrbin C.M., Geisinger K.R. Urine cytology discrepancies: frequency, causes, and outcomes. Am J Clin Pathol 2007;127(6):946–53. PMID: 17509992. DOI: 10.1309/XUVXFXMFPL7TELCE.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Rosenthal D.L., Vandenbussche C.J., Burroughs F.H. et al. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template. Cancer Cytopathol 2013;121(1):15–20. PMID: 23192944. DOI: 10.1002/cncy.21255.</mixed-citation><mixed-citation xml:lang="ru">Rosenthal D.L., Vandenbussche C.J., Burroughs F.H. et al. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template. Cancer Cytopathol 2013;121(1):15–20. PMID: 23192944. DOI: 10.1002/cncy.21255.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Ubago J.M., Mehta V., Wojcik E.M., Barkan G.A. Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol 2013;121(7):387–91. PMID: 23536358. DOI: 10.1002/cncy.21278.</mixed-citation><mixed-citation xml:lang="ru">Ubago J.M., Mehta V., Wojcik E.M., Barkan G.A. Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol 2013;121(7):387–91. PMID: 23536358. DOI: 10.1002/cncy.21278.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Koss L.G., Hoda R.S. Koss’s cytology of the urinary tract with histopathology correlations. New York: Springer Press, 2012.</mixed-citation><mixed-citation xml:lang="ru">Koss L.G., Hoda R.S. Koss’s cytology of the urinary tract with histopathology correlations. New York: Springer Press, 2012.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Hoda R.S. Non-gynecologic cytology on liquid-based preparations: 3 morphologic review of facts and artifacts. Diagn Cytopathol 2007;35(10):621–34. PMID: 17854077. DOI: 10.1002/dc.20698.</mixed-citation><mixed-citation xml:lang="ru">Hoda R.S. Non-gynecologic cytology on liquid-based preparations: 3 morphologic review of facts and artifacts. Diagn Cytopathol 2007;35(10):621–34. PMID: 17854077. DOI: 10.1002/dc.20698.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Khaled H. Schistosomiasis and cancer in Egypt review. J Adv Res 2013;4(5):461–6. PMID: 25685453. PMCID: PMC4293882. DOI: 10.1016/j.jare.2013.06.007.</mixed-citation><mixed-citation xml:lang="ru">Khaled H. Schistosomiasis and cancer in Egypt review. J Adv Res 2013;4(5):461–6. PMID: 25685453. PMCID: PMC4293882. DOI: 10.1016/j.jare.2013.06.007.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Hattori M., Nishimura Y., Toyonaga M. et al. Cytological significance of abnormal squamous cells in urinary cytology. Diagn Cytopathol 2012;40(9):798–803. PMID: 21309015. DOI: 10.1002/dc.21645.</mixed-citation><mixed-citation xml:lang="ru">Hattori M., Nishimura Y., Toyonaga M. et al. Cytological significance of abnormal squamous cells in urinary cytology. Diagn Cytopathol 2012;40(9):798–803. PMID: 21309015. DOI: 10.1002/dc.21645.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Gulmann C., Paner G.P., Parakh R.S. et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol 2013;44(2):164–72. PMID: 22995333. DOI: 10.1016/j.humpath.2012.05.018.</mixed-citation><mixed-citation xml:lang="ru">Gulmann C., Paner G.P., Parakh R.S. et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol 2013;44(2):164–72. PMID: 22995333. DOI: 10.1016/j.humpath.2012.05.018.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Zhong M., Gersbach E., Rohan S.M., Yang X.J. Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance. Arch Pathol Lab Med 2013;137(3);371–81. PMID: 23451748. DOI: 10.5858/arpa.2012-0076-RA.</mixed-citation><mixed-citation xml:lang="ru">Zhong M., Gersbach E., Rohan S.M., Yang X.J. Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance. Arch Pathol Lab Med 2013;137(3);371–81. PMID: 23451748. DOI: 10.5858/arpa.2012-0076-RA.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Bardales R.H., Pitman M.B., Stanley M.W. et al. Urine cytology of primary and secondary urinary bladder adenocarcinoma. Cancer 1998;84(6):335–43. PMID: 9915134.</mixed-citation><mixed-citation xml:lang="ru">Bardales R.H., Pitman M.B., Stanley M.W. et al. Urine cytology of primary and secondary urinary bladder adenocarcinoma. Cancer 1998;84(6):335–43. PMID: 9915134.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Ciesla M.C., Guidos B.J., Selvaggi S.M. Cytomorphology of small-cell (neuroendocrine) carcinoma on Thin Prep cytology as compared to conventional smears. Diagn Cytopathol 2001;24(1):46–52. PMID: 11135469.</mixed-citation><mixed-citation xml:lang="ru">Ciesla M.C., Guidos B.J., Selvaggi S.M. Cytomorphology of small-cell (neuroendocrine) carcinoma on Thin Prep cytology as compared to conventional smears. Diagn Cytopathol 2001;24(1):46–52. PMID: 11135469.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Dahm P., Gschwend J.E. Malignant nonurothelial neoplasms of the urinary bladder: a review. Eur Urol 2003;44(6):672–81. PMID: 14644119.</mixed-citation><mixed-citation xml:lang="ru">Dahm P., Gschwend J.E. Malignant nonurothelial neoplasms of the urinary bladder: a review. Eur Urol 2003;44(6):672–81. PMID: 14644119.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. Chalasani V., Chin J.L., Izawa J.I. Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J 2009;3(6 Suppl 4):193–8. PMID: 20019984. PMCID: PMC2792446.</mixed-citation><mixed-citation xml:lang="ru">Chalasani V., Chin J.L., Izawa J.I. Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J 2009;3(6 Suppl 4):193–8. PMID: 20019984. PMCID: PMC2792446.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. Abol-Enein H., Kava B.R., Carmack A.J. Nonurothelial cancer of the bladder. Urology 2007;69(1 Suppl): 93–104.</mixed-citation><mixed-citation xml:lang="ru">Abol-Enein H., Kava B.R., Carmack A.J. Nonurothelial cancer of the bladder. Urology 2007;69(1 Suppl): 93–104.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32. Westfall D.E., Folpe A.L., Paner G.P. et al. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol 2009;33(1):99–105. PMID: 18941404. DOI: 10.1097/PAS.0b013e318180c899.</mixed-citation><mixed-citation xml:lang="ru">Westfall D.E., Folpe A.L., Paner G.P. et al. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol 2009;33(1):99–105. PMID: 18941404. DOI: 10.1097/PAS.0b013e318180c899.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33. Cheson B.D., Schumann J.L., Schumann G.B. Urinary cytodiagnostic abnormalities in 50 patients with non-Hodgkin’s lymphomas. Cancer 1984;54(9):1914–9. PMID: 6478425.</mixed-citation><mixed-citation xml:lang="ru">Cheson B.D., Schumann J.L., Schumann G.B. Urinary cytodiagnostic abnormalities in 50 patients with non-Hodgkin’s lymphomas. Cancer 1984;54(9):1914–9. PMID: 6478425.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34. Jimenez-Hernandez M., Lopez-Guillermo A., Cobo F. et al. Bladder involvement of diffuse large B-cell lymphoma diagnosed by a cytological study of the urine. Leuk Lymphoma 2002;43(1):187–9. PMID: 11908726. DOI: 10.1080/10428190210201.</mixed-citation><mixed-citation xml:lang="ru">Jimenez-Hernandez M., Lopez-Guillermo A., Cobo F. et al. Bladder involvement of diffuse large B-cell lymphoma diagnosed by a cytological study of the urine. Leuk Lymphoma 2002;43(1):187–9. PMID: 11908726. DOI: 10.1080/10428190210201.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35. Khalbuss W.E., Hossain M., Elhosseiny A. Primary malignant melanoma of the urinary bladder diagnosed by urine cytology: a case report. Acta Cytol 2001;45(4):631–5. PMID: 11480732.</mixed-citation><mixed-citation xml:lang="ru">Khalbuss W.E., Hossain M., Elhosseiny A. Primary malignant melanoma of the urinary bladder diagnosed by urine cytology: a case report. Acta Cytol 2001;45(4):631–5. PMID: 11480732.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36. Xiao G.Q., Chow J., Unger P.D. Metastatic tumors to the urinary bladder: clinic pathologic study of 11 cases. Int J Surg Pathol 2012;20(4):342–8. PMID: 22134629. DOI: 10.1177/1066896911428736.</mixed-citation><mixed-citation xml:lang="ru">Xiao G.Q., Chow J., Unger P.D. Metastatic tumors to the urinary bladder: clinic pathologic study of 11 cases. Int J Surg Pathol 2012;20(4):342–8. PMID: 22134629. DOI: 10.1177/1066896911428736.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
